Ultraman angrily confronts Musk: he is just a "bully" who likes to "fight" with opponents.

Altman believes that Musk's hostility towards OpenAI largely stems from its success. He also mentioned that Musk had "high-profile" arguments with Jeff Bezos and Bill Gates.

wallstreetcn17:13

A retrospective on the OpenAI series of conferences: From tools to AGI, the evolution of OpenAI in 12 days.

In the first four days, the official version of o1, Sora, and Canvas were launched with great impact; after a few days of 'silence' in between, the last day directly revealed a game-changer—GPT-o3, which broke the skepticism surrounding the bottleneck in AI development.

Tencent Technology15:35

Eli Lilly's Zepbound Receives FDA Approval For Obesity-Linked Sleep Apnea Drug

Benzinga12:48

Musk causes a commotion at Capitol Hill, is a "Trump 2.0" prototype emerging?

Analysis suggests that Musk's recent act of detonating a political nuclear bomb may be a rehearsal for the Trump 2.0 era of Musk's action model, intended to exert pressure on Congress. However, some also say that the consensus at Mar-a-Lago is that Musk has proven to be an effective Weapon to pressure Congress and a scapegoat for any backlash.

wallstreetcn12:21

Eli Lilly and Co's Zepbound has been approved by the FDA for the treatment of obstructive sleep apnea.

① The FDA in the USA approved Eli Lilly and Co's weight loss medication Zepbound on Friday for the treatment of obstructive sleep apnea (OSA), making it the first drug approved for directly treating this common sleep disorder; ② The active ingredient in Zepbound is Tirzepatide, which was initially used to treat type 2 diabetes, namely Eli Lilly and Co's Mounjaro.

cls.cn11:45

Weekend reading | Zuckerberg and Ultraman launch the "second chip war".

Looking back at 2024 and looking forward to 2025, let insights transcend time to seek certainty for the future. This issue focuses on the chip networks and computing power of Silicon Valley giants.

Tencent Technology10:49